Literature DB >> 16330099

Antimicrobial peptide defenses of the mountain yellow-legged frog (Rana muscosa).

Louise A Rollins-Smith1, Douglas C Woodhams, Laura K Reinert, Vance T Vredenburg, Cheryl J Briggs, Per F Nielsen, J Michael Conlon.   

Abstract

The mountain yellow-legged frog (Rana muscosa) inhabits high elevation lakes in California that are largely undisturbed by human activities. In spite of this habitation in remote sites, populations continue to decline. Although predation by non-native fish is one cause for declines, some isolated populations in fishless lakes are suffering new declines. One possible cause of the current wave of declines is the introduction of the pathogenic chytrid fungus (Batrachochytrium dendrobatidis) which invades the adult skin to cause chytridiomycosis. In many amphibian species, the skin is protected by antimicrobial peptides secreted into the mucous. Here we show that R. muscosa produces three previously unknown antimicrobial peptides belonging to the ranatuerin-2 and temporin-1 families of antimicrobial peptides. These three peptides, along with bradykinin, are the most abundant peptides in the skin secretions detected by mass spectrometry. Natural mixtures of peptides and individual purified peptides strongly inhibit chytrid growth. The concentration of total peptides recovered from the skin of frogs following a mild norepinephrine induction is sufficient to inhibit chytrid growth in vitro. A comparison of the species susceptibility to chytridiomycosis and the antichytrid activity of peptides between R. muscosa and R. pipiens suggest that although R. muscosa produces more total skin peptides, it appears to be more vulnerable to B. dendrobatidis in nature. Possible differences in the antimicrobial peptide repertoires and life history traits of the two species that may account for differences in susceptibility are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16330099     DOI: 10.1016/j.dci.2005.10.005

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  25 in total

1.  Immmunological clearance of Batrachochytrium dendrobatidis infection at a pathogen-optimal temperature in the hylid frog Hypsiboas crepitans.

Authors:  M Márquez; F Nava-González; D Sánchez; M Calcagno; M Lampo
Journal:  Ecohealth       Date:  2010-10-02       Impact factor: 3.184

2.  Immune defenses against Batrachochytrium dendrobatidis, a fungus linked to global amphibian declines, in the South African clawed frog, Xenopus laevis.

Authors:  Jeremy P Ramsey; Laura K Reinert; Laura K Harper; Douglas C Woodhams; Louise A Rollins-Smith
Journal:  Infect Immun       Date:  2010-06-28       Impact factor: 3.441

3.  First evidence of Batrachochytrium dendrobatidis in China: discovery of chytridiomycosis in introduced American bullfrogs and native amphibians in the Yunnan Province, China.

Authors:  Changming Bai; Trenton W J Garner; Yiming Li
Journal:  Ecohealth       Date:  2010-04-06       Impact factor: 3.184

4.  Evaluation of amphotericin B and chloramphenicol as alternative drugs for treatment of chytridiomycosis and their impacts on innate skin defenses.

Authors:  Whitney M Holden; Alexander R Ebert; Peter F Canning; Louise A Rollins-Smith
Journal:  Appl Environ Microbiol       Date:  2014-04-25       Impact factor: 4.792

5.  Large-scale recovery of an endangered amphibian despite ongoing exposure to multiple stressors.

Authors:  Roland A Knapp; Gary M Fellers; Patrick M Kleeman; David A W Miller; Vance T Vredenburg; Erica Bree Rosenblum; Cheryl J Briggs
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

6.  Global gene expression profiles for life stages of the deadly amphibian pathogen Batrachochytrium dendrobatidis.

Authors:  Erica Bree Rosenblum; Jason E Stajich; Nicole Maddox; Michael B Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-13       Impact factor: 11.205

7.  Variations in the expressed antimicrobial peptide repertoire of northern leopard frog (Rana pipiens) populations suggest intraspecies differences in resistance to pathogens.

Authors:  Jacob A Tennessen; Douglas C Woodhams; Pierre Chaurand; Laura K Reinert; Dean Billheimer; Yu Shyr; Richard M Caprioli; Michael S Blouin; Louise A Rollins-Smith
Journal:  Dev Comp Immunol       Date:  2009-08-03       Impact factor: 3.636

8.  Synergistic inhibition of the lethal fungal pathogen Batrachochytrium dendrobatidis: the combined effect of symbiotic bacterial metabolites and antimicrobial peptides of the frog Rana muscosa.

Authors:  Jillian M Myers; Jeremy P Ramsey; Alison L Blackman; A Elizabeth Nichols; Kevin P C Minbiole; Reid N Harris
Journal:  J Chem Ecol       Date:  2012-08-23       Impact factor: 2.626

9.  Evaluation of Presurgical Skin Preparation Agents in African Clawed Frogs (Xenopus laevis).

Authors:  Blythe H Philips; Marcus J Crim; F Claire Hankenson; Earl K Steffen; Peter S Klein; Angela K Brice; Anthony J Carty
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-11       Impact factor: 1.232

10.  Microbiota and skin defense peptides may facilitate coexistence of two sympatric Andean frog species with a lethal pathogen.

Authors:  Sandra V Flechas; Alejandro Acosta-González; Laura A Escobar; Jordan G Kueneman; Zilpa Adriana Sánchez-Quitian; Claudia M Parra-Giraldo; Louise A Rollins-Smith; Laura K Reinert; Vance T Vredenburg; Adolfo Amézquita; Douglas C Woodhams
Journal:  ISME J       Date:  2018-09-25       Impact factor: 10.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.